UB faculty members Glenna Bett and Randall Rasmusson are among
the latest wave of entrepreneurs flooding START-UP NY, making our
region the leader with at least 42 companies. Their company -
CytoCybernetics - is developing technology that would make
prescription drugs safer.
SUNY Distinguished Professor Paras Prasad made sure his
groundbreaking research went to work. A world leader in
nanomedicine, he licensed his technologies to UB spinoff
Nanobiotix, now a publicly traded company based in France. The
results earned him UB's first Innovation Impact Award.